Application-related properties of a new fast dispersible excipient

Pharmaceutical Technology Europe

Volumn 21, Issue 1, 2009, Pages 24-27

  Mistry, Maureen ^a  

^a BASF Pharma Ingredients and Services Europe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CROSPOVIDONE; EXCIPIENT; LOPERAMIDE; MANNITOL; PARACETAMOL; POLYVINYL ACETATE;

COMPRESSIVE STRENGTH; DISPERSIBLE TABLET; DRUG DELIVERY SYSTEM; DRUG PACKAGING; HUMAN; PATENT; REVIEW; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET HARDNESS; TABLET MACHINE; TABLET MANUFACTURE; TABLET POROSITY;

EID: 58249112329     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. K. Kolter et al., Controlled Release Society 34th Annual Meeting and Exposition (Long beach, California, USA, July 2007).
2. FDA Guidance for Industry - Orally Disintegrating Tablets draft guidance, April 2007. www.fda.gov
3. K. Cremer, Orally disintegrating dosage forms (2001). www.pharma-concepts.com
4. European Pharmacopoeia Supplement 6.3.
5. K. Kolter et al., AAPS (San Diego, CA, USA, November 2007).
6. D. Brown, Drug Delivery Technology, 3(6) (2003).
7. R. Widmaier, "Technologies for orally disintegrating tablets: A short introduction" (BASF, Ludwigshafen, 2007).
8. BASF SE, Technical information on Ludiflash (2008). www.basf.com
9. K. Kolter et al., APV world meeting (Barcelona, Spain, April 2008).
10. T. Harmon, Orally disintegrating Tablets: A Valuable life cycle management strategy (Pharmaceutical Commerce, March 2000).